| Literature DB >> 3818785 |
P E Postmus, N H Mulder, D L Schipper, E G de Vries.
Abstract
Vindesine 1.75 mg/m2, twice weekly for 2 weeks followed by 2 weeks rest, was given to 26 lung cancer patients. In 6 patients a partial response was seen (23%). Neurotoxicity was present in 15 patients after 1 course; in 6 patients this was the reason for stopping therapy. This regimen has no advantage over weekly vindesine.Entities:
Mesh：
Substances：
Year: 1987 PMID： 3818785 DOI： 10.1007/bf00389975
Source DB: PubMed Journal: J Cancer Res Clin Oncol ISSN： 0171-5216 Impact factor: 4.553